Medicus Pharma Ltd. Common Stock (MDCX NASDAQ) stock market data APIs
$0.162
-0(-0%)
as of September 11, 2026
Try our APIs with
free plan!
Medicus Pharma Ltd. Common Stock Financial Data Overview
Price chart is built with
Anychart
Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin. The company has a strategic collaboration with the Gorlin Syndrome Alliance to access to SKINJECT in Patients with Gorlin Syndrome. The company was formerly known as Interactive Capital Partners Corporation and changed its name to Medicus Pharma Ltd. in September 2023. The company was incorporated in 2008 and is headquartered in West Conshohocken, Pennsylvania.
Prev. Close
0.162
Open
0.1584
High
0.1621
Low
0.1542
52 wk Range
0.151-3.05
Market Cap
10 273 K
Shares Outstanding
63 181 K
EPS
-0.21
Beta
-0.481
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Medicus Pharma Ltd. Common Stock data using free add-ons & libraries
Get Medicus Pharma Ltd. Common Stock Fundamental Data
Medicus Pharma Ltd. Common Stock Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: -2
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Medicus Pharma Ltd. Common Stock Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-08-12
- EPS/Forecast: -0.14
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Medicus Pharma Ltd. Common Stock News
New
Medicus Pharma secures Pfizer ADC deal, advances SkinJect and precision oncology strategy
Medicus Pharma CEO Dr Raza Bokhari joined Steve Darling from Proactive to discuss a transformative agreement with Pfizer that significantly strengthens the company's position in precision oncology and...
Medicus Secures United Arab Emirates DOH Authorization For Phase 2a Teverelix Trial In Endometriosis
(RTTNews) - Medicus Pharma Ltd. (MDCX) announced that the Department of Health (DOH) - Abu Dhabi has granted Investigational New Drug (IND) authorization, for the Phase 2a PRECISION-E2 genomics-enable...
Medicus To Continue Phase 2 For SkinJect In Carcinoma With FDA Recommendations; Stock Falls 12%
(RTTNews) - Medicus Pharma Inc. (MDCX), a biotech/life sciences company, on Tuesday announced the receipt of a 'Study May Proceed' notification from the U.S. Food and Drug Administration (FDA), allowi...
Medicus Pharma Receives FDA “Study May Proceed” Letter for NDA-Enabling Registrational SkinJect® Study in Patients with Gorlin Syndrome
PHILADELPHIA, July 27, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) (“Medicus” or the “Company”), a biotech/life sciences company focused on advancing the clinical development...
Get Medicus Pharma Ltd. Common Stock fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
